Bioequivalence Study Of Pediatric Appropriate Formulation

NCT00758004 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: Atorvastatin
DRUG: Atorvastatin pediatric appropriate formulation

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.